Treatment effects on pain catastrophizing and cutaneous allodynia symptoms in women with migraine and overweight/obesity.
Treatment effects on pain catastrophizing and cutaneous allodynia symptoms in women with migraine and overweight/obesity.
复制标题
DOI:
10.1037/hea0000920
复制
发表时间:
2020-10
期刊:
影响因子:
--
通讯作者:
Bond DS
中科院分区:
文献类型:
--
作者:
Farris SG;Thomas JG;Kibbey MM;Pavlovic JM;Steffen KJ;Bond DS
Pain catastrophizing and cutaneous allodynia represent two risk factors for greater headache-related disability. Yet, there is limited knowledge of the extent to which these risk factors are modifiable and whether non-pharmacological treatment-related changes are associated with migraine improvements. Using data from the Women’s Health and Migraine (WHAM), a randomized controlled trial that compared effects of behavioral weight loss (BWL) and migraine education (ME) in women with migraine and overweight/obesity, we tested whether: (a) BWL v ME produced greater changes in pain catastrophizing and allodynia from baseline across post-treatment and follow-up time points and (b) whether these improvements were associated with improvements in headache disability. Women (n = 110) were randomly assigned to 16 weeks of either BWL or ME and assessed at baseline, post-treatment, and follow-up (32 weeks). Multilevel mixed effects modeling tested: (a) for between-group differences in pain catastrophizing and allodynia changes over time, and (b) associations of changes in pain catastrophizing and allodynia with changes in headache disability, adjusting for migraine severity and weight loss. Both BWL and ME had significant reductions in pain catastrophizing and allodynia from baseline to post-treatment and follow-up, and the improvements were comparable across conditions. Reductions in pain catastrophizing and cutaneous allodynia were associated with significant reductions in headache disability, even when controlling for intervention-related improvements in migraine and weight loss. Pain catastrophizing and allodynia are not only reduced after non-pharmacologic treatments for migraine, but greater improvements are associated with greater reductions in headache-related disability, independent of migraine severity.
登录
查看更多内容
影响因子:
3.7
作者:
Oshinsky, Michael L
通讯作者:
Oshinsky, Michael L
影响因子:
5
作者:
Bond DS;Buse DC;Lipton RB;Thomas JG;Rathier L;Roth J;Pavlovic JM;Evans EW;Wing RR
通讯作者:
Wing RR
影响因子:
5
作者:
Dodick, David;Silberstein, Stephen
通讯作者:
Silberstein, Stephen
DOI:
10.1186/s10194-017-0748-8
发表时间:
2017-12
期刊:
The journal of headache and pain
影响因子:
--
作者:
Galioto R;O'Leary KC;Thomas JG;Demos K;Lipton RB;Gunstad J;Pavlović JM;Roth J;Rathier L;Bond DS
通讯作者:
Bond DS
影响因子:
11.2
作者:
Burstein, R;Collins, B;Jakubowski, M
通讯作者:
Jakubowski, M